Companies and Markets
Market Research A to Z | Company Profiles A to Z | Register | Contact Us
Log In
+44 (0) 203 086 8600 Call us on
All SectorsAerospaceAgriculture, Farming & Raw MaterialsAutomotive and PartsBusiness ServicesChemicalsConstruction
IndustrialInformation TechnologyLeisureLogisticsMediaPaper and PackagingPublishing and Printing
Real EstateRetailSecurityTelecommunicationsTextiles and ClothingTransportationTravel
Consumer GoodsDefenceEnergy and UtilitiesEnvironmentalFinance and BankingFood and DrinkHealthcare and Medical
Healthcare and Medical
Healthcare and Medical
Type
Keywords

Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.
Country
Industry Sector
Publisher
Order By
Published In
Advanced Search
Home >Market >Healthcare and Medical >Market Research

Analysis of European Biosimilars Market

Report Overview
4267.16

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£4,267.16
Add to Wishlist

Change Currency

 GBP EURO USD
Order By Fax

Market

 Healthcare and Medical

Report Type

 Market Research

Country

 Europe

Published

20 December 2011

Number of Pages

223

Report Delivery

Email

Delivery Lead Time

1-3 hours, 24 hour max

Publisher

 Frost and Sullivan

File Format

PDF

Impending patent expiries of blockbuster biologics spells good news for biosimilars in Europe

The biosimilars manufacturing industry is at a nascent stage. However, the impending patent expiries of biologics are anticipated to result in the introduction of several new biosimilars and provide impetus to market development. The expiration of patents and other intellectual property rights of biological innovators over the next decade opens up opportunities for biosimilars to enter the market and increase industry competition. Price reduction strategies will ensure increased adoption among physicians and patients alike, spurring market advancement.

While the market offers lucrative growth prospects, the need for sizeable investments will pose a serious challenge to smaller firms. Complex production processes, expensive biological and chemical materials, and rigorous clinical trials as well as mandatory safety, efficacy and quality tests require significant investments. The need for considerable financial outlays will hinder the entry of small biotech firms in particular. On the other hand, specialty pharmaceutical companies with biotech expertise and financial capabilities are well positioned to venture into the biosimilars market. High manufacturing costs are another major barrier to market entry. However, there are viable prospects for licensing agreements between companies.

Effective Sales and Marketing Strategies Critical to Successful Commercialisation

The uncertainties and risks for biosimilars manufacturers persist. Companies need to have strongly integrated research and development (R&D), production, sales and marketing processes to ensure market success.

Access to sales and marketing capabilities can be achieved through collaborations between pharmaceutical companies and specialty biotech firms with technical expertise. Companies can build sales and marketing capabilities in-house and ensure effective marketing support for the commercialisation of biosimilars. Effective sales communication to the scientific community, coupled with continuous promotional activities as well as close and constant interaction with doctors and pharmacists, will promote greater uptake of biosimilars.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following product segments in this research:

- Existing biosimilars (erythropoietin, granulocyte colony stimulating factors and human growth hormones)
- Emerging biosimilars (monoclonal antibodies, insulin and interferon - alpha and beta)

By Geographic Region:

- United Kingdom
- Germany
- France
- Italy
- Spain
- Benelux (Belgium, Netherlands and Luxembourg)
- Scandinavia (Denmark, Norway and Sweden)

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£4,267.16
Add to Wishlist

Change Currency

 GBP EURO USD

Visitor Comments

All Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
EURO
USD

Last Viewed

Analysis of European Biosimilars Market

Healthcare and Medical Company Profiles

Find latest Healthcare and Medical Company Profiles with up to date financial, strategic, operational, SWOT analysis and product information for the leading healthcare and medical companies.

Competitor Tracking

Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

News

Digital pathology market to reach a value of $542 million by 2018

Infectious disease treatments market driven by growth in middle-income to low-income countries

OCT imaging market led by Carl Zeiss and St. Jude Medical

Healthcare decision support market led by McKesson and IBM's Watson

Intraocular lenses market driven by the increase in the prevalence of cataract among the aging population

Market Insights

Global Obesity Market

Global Medical Market Insight

ECG Devices Market

Czech Republic Veterinary Market Insight

Cardiovascular Devices Market

Latest News and Markets Insights

Companies And Markets

Home

Business News Team

About Us

Our Clients

Publishers

Become A Publisher

Become An Affiliate

Business News

Market Insights

Jobs

Contact Us

SiteMap

Customer Support

How to Purchase

Frequently Asked Questions

Register Now

Home

Customer Support Form

Pricing And Licenses

Email Alerts

Custom Research Services

Terms And Conditions

Our Report Types

Legals

Free Research Support

Corporate Accounts

Subscription Accounts

Competitor Tracking

eBrandPromote: Promote your Brand Online

Contact Details

Vertical Edge Limited
(www.companiesandmarkets.com)
Unit 6 (3rd floor) Tabernacle Court
16-28 Tabernacle Street
London, EC2A 4DD
United Kingdom

Email
enquiries@companiesandmarkets.com

Telephone
+44 (0) 203 086 8600

Accessibility
Close

Contrast settings

Text size settings